Over the past few years, incidences of cardiovascular diseases have been witnessing a surge, coupled with the rising number of cardiology intervention procedures around the world. Governments are making provisions of reimbursement support for patients with vascular diseases.
Healthcare expenditure has also been experiencing a hike in the recent past. Factors such as these may impact the growth of the global normal balloon catheter market. In addition, numerous other factors including rising in the elder population, increasing investments in R&D activities associated with normal balloon catheters are further estimated to create growth opportunities for normal balloon catheter manufacturers.
Request a report sample to gain comprehensive insights at https://www.factmr.com/connectus/sample?flag=S&rep_id=147
The global market for normal balloon catheters is set to exhibit an average CAGR throughout the forecast period (2017-2022). The global normal balloon catheter market will account for around US$ 2,000 Mn revenues by 2022-end.
However, factors such as high costs related to angioplasty procedures, along with risks concerning balloon catheterization including infection and artery collapse are anticipated to curb the growth of the global market for the normal balloon catheter.
Trends Being Observed in the Global Normal Balloon Catheter Market
- Rise in interventional cardiology is facilitating the use of the normal balloon catheters
- Surging prevalence of patients with end-stage renal disease have been fuelling demand for normal balloon catheters
- The number of people undergoing renal replacement therapy is increasing, thereby fuelling the growth of the normal balloon catheter market
Normal balloon catheter sales in cardiac catheterization laboratories will register the fastest expansion over the forecast period, on the basis of end-users. In addition, hospitals are expected to retain their dominance in the global market for normal balloon catheters.
Hospitals to Remain the Largest End-Users of Normal Balloon Catheter
Sales of normal balloon catheter in cardiac catheterization laboratories are expected to exhibit the fastest expansion through 2022, based on end-users. Hospitals will remain the largest end-users of normal balloon catheter throughout the forecast period.
Nylon will continue to be the preferred raw material for manufacturing normal balloon catheter. Nearly half the revenue share of the market will be accounted for nylon, based on raw material. However, sales of polyurethane for the production of normal balloon catheter will register a comparatively higher CAGR than sales of nylon through 2022.
Request More Information about Report Methodology
Nylon to be Sought-after among Manufacturers of Normal Balloon Catheters
Based on raw material, nylon will remain sought-after among manufacturers of normal balloon catheters. Approximately half market share will be held by sales of nylon in the market during the forecast period. In addition, sales of polyurethane in the global market is expected to exhibit a relatively higher CAGR than that of nylon through 2022.
Coronary artery disease will continue to be dominant in the market, based on the indication. Sales of normal balloon catheters for coronary artery disease are anticipated to exceed revenues worth US$ 1,000 Mn by 2022-end. In terms of revenue, nearly three-fourth market share is estimated to be held by normal balloon catheter sales for coronary artery disease throughout the forecast period.
Europe to Account for Largest Revenue Share of the Global Normal Balloon Catheter Market
Europe is projected to be the largest market for normal balloon catheter from 2017 to 2022, in terms of revenue. Sales of a normal balloon catheter in Europe will hold the largest revenue share of the market over the forecast period. In addition, normal balloon catheter sales in Asia-Pacific excluding Japan (APEJ) are expected to exhibit the fastest expansion through 2022. In contrast, the market in North America is anticipated to register the lowest CAGR through 2022.
Key market players profiled in the report include BIOTRONIK SE & Co. KG., Cordis Corporation, Cook Medical INC, Tokai Medical Products Inc., Hexacath, Meril Life Sciences Pvt. Ltd., B. Braun Melsungen AG, MicroPort Scientific Corporation, Terumo Corporation, Medtronic plc, Boston Scientific Corporation, and Abbott Laboratories.
Explore Wide-ranging Coverage of Fact.MR’s Healthcare Landscape
Asthma Spacers Market: Find insights on the Asthma Spacers market with analysis of segments, statistics, influencers, market players, and business strategies adopted over a 10-year forecast period.
Diverticular Disease Therapeutics Market: Fact.MR’s report on the diverticular disease therapeutics market offers insights on the market during 2018-2028, including restraints, revenue sources, market leaders, and market strategies.
Tumour-Induced Osteomalacia Market: Read an analysis of the tumour-induced osteomalacia market with insights on growth factors, opportunities, restraints, regional market forecast, regulatory policies, and strengths of market leaders.
Market research and consulting agency with a difference! That’s why 80% of Fortune 1,000 companies trust us for making their most critical decisions. We have offices in US and Dublin, whereas our global headquarter is in Dubai. While our experienced consultants employ the latest technologies to extract hard-to-find insights, we believe our USP is the trust clients have on our expertise. Spanning a wide range – from automotive & industry 4.0 to healthcare & retail, our coverage is expansive, but we ensure even the most niche categories are analyzed. Reach out to us with your goals, and we’ll be an able research partner.
US Sales Office:
11140 Rockville Pike
Rockville, MD 20852
Tel: +1 (628) 251-1583
Research Insight: https://www.factmr.com/report/147/normal-balloon-catheter-market
Press Release: https://www.factmr.com/media-release/136/normal-balloon-catheter-market
Follow Us: LinkedIn | Twitter